BenchSci Stock

BenchSci uses machine learning and artificial intelligence to accelerate biomedical discoveries.

Sign up today and learn more about BenchSci Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About BenchSci Stock

BenchSci uses AI to empower scientists to run more successful experiments to accelerate drug discovery. The company empowers scientists with advanced biomedical artificial intelligence to run more successful experiments. Backed by F-Prime, Gradient Ventures (Google’s AI fund), and Inovia Capital, BenchSci's proprietary technology accelerates science pharmaceutical companies and over 4,300 research centers worldwide.

Funding History

October 2016$254K
July 2017$2.5M
May 2018$10.2M
June 2019$6.7M
February 2020$22.0M
February 2020$7.5M
January 2022$63.0M
May 2023$95.0M

Management

CDO and Co-founder

Elvis Wianda

Co-founder & CEO

Liran Belenzon

CSO and Co-founder

Tom Leung

Chief Platform Officer

Eran Ben-Ari

Board Member

Antoine Nivard

Director Board Of Directors

Luba Greenwood

Director

Bert Amato

Engineering Manager, Machine Learning

Anmol Sharma

Vice President of Business Operations & Delivery

Rasheed Ahmed

Chief People Officer

Vanessa Ribreau

Chief Strategy Officer

Simon Smith

Chief Architect Officer

Craig Newell

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo